万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>期刊大全 >>SCI/SCIE期刊 >>医药卫生>>生物病理学

Oncogene(研究方向:生化与分子生物学) (官网投稿)

简介
Oncogene(周刊),创刊于1987年,出版国家为英国。Oncogene旨在通过发表杰出的研究,在我们对促进癌症的过程的知识方面取得实质性进展。我们建立在以前的研究上提出适当的猜想,特别是那些导致在病理发病机制,诊断,治疗或预防癌症和驱动转移扩散的过程中建立新的范例,并提供重要的见解癌症生物学超越迄今已经揭示的。Oncogene覆盖的区域包括但不限于癌症的细胞和分子生物学,包括对癌症治疗的抗性,以及开发改善生存的更好方法。在癌症生物...[显示全部]
本刊为:SCI期刊(2015-2016), SCIE期刊(2015-2016), 外文期刊,
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:http://www.nature.com/onc/index.html

3、期刊投稿:

http://mts-onc.nature.com/cgi-bin/main.plex

4、官网邮箱:oncogene@natureny.com

5、编辑部地址:Nature Publishing Group, 75 Varick Street, 9th Floor

New York, NY 10013-1917, USA

6、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

2017214日星期二

                      

 

Instructions for Authors

 

Aims and Scope

Oncogene aims to make substantial advances in our knowledge of the processes that contribute to cancer by publishing outstanding research. We propagate work that challenges standard conjecture and builds on previous studies, in particular those that lead to establishing new paradigms in the etio-pathogensis, diagnosis, treatment, or prevention of cancers, and in processes that drive metastatic spread, and provide important insights into cancer biology beyond what has been revealed thus far. Areas covered by Oncogene include but are not limited to, the cellular and molecular biology of cancer including resistance to cancer therapies, and development of better approaches to improving survival. Across cancer biology, we have a broad remit encompassing the life sciences and biomedicine, from the most fundamental and theoretical work, through to translational, applied, and clinical research. Our Editors are among the most respected and accomplished individuals in their fields – from genetics and structural biology, to function and mechanism.

 

Journal Details

Editors-in-Chief:

Douglas R Green

St Jude Children’s Research Hospital

Memphis, Tennessee, USA

Justin Stebbing

Imperial College, London, UK

Editorial office:

Springer Nature

One New York Plaza, Suite 4500

New York, NY 10004-1562

oncogene@us.nature.com

ARTICLE TYPE SPECIFICATIONS

 

Original Articles (Please see ‘Preparation of Articles’ below for further details) Manuscripts describing novel experimental findings with more than four figures and/or tables. Keep the text as brief and clear as possible, and prepare figures to occupy a minimum of space. The Results and the Discussion must be presented as two separate sections.

Full-length papers must not exceed a total of 4,500 words (excluding abstract, references and figure legends). Papers exceeding this word limit will be returned to the authors.Include the word count for your manuscript in your cover letter.

Review articles are summaries of a large field of research. Submissions are typically by Editor invitation only; however, occasionally unsolicited Reviews may be considered. For any inquiries or to propose a Review topic for consideration, please contact the editorial office: oncogene@us.nature.com. Review articles must not exceed 6,000 words. Articles exceeding this word limit will be returned to the authors.

Short Communications

A short communication is a concise, independent report representing a significant and timely contribution to cancer biology. A short communication is not intended to publish preliminary results. The results must be of exceptional interest and relevant to be considered for publication.

The text should be organized with an Introduction, and the Results and Discussion sections should be combined. All Materials and Methods should be included in the figure legends. The text must be succinctly written, and figures (no more than four) prepared to occupy a minimum of space.

Short Communications must not exceed a total of 2,500 words (excluding the abstract, references and legends). Papers exceeding this word limit will be returned to the authors. Include a word count for your manuscript in your cover letter.

Letters to the Editor

Letters to the Editor will be considered for publication, subject to editing.

Letters must contain information critical to a certain area or must be confirmatory of data recently published in Oncogene.

Letters must reference the original source, and a Response to a Letter must reference the Letter in the first few paragraphs, as well as the original source.

Letters can use an arbitrary title, but a Response must cite the title of the Letter: e.g. Response to [title of Letter].

All Letters must contain a title page including all authors’ names and affiliations and corresponding author contact information.

Letters must not exceed 400 words (not including references). There is a limit of five references. The first reference must be the citation for the original article under discussion.

Letters may contain figures or tables (up to two each) only if they show data that refute the original article’s conclusions. Figures or tables showing unpublished data in support of the original article’s conclusions will not be considered.

 

HOW TO SUBMIT

Pre-submission Inquiries

Oncogene implements a first round review of papers by our team of Deputy Editors to determine article suitability prior to full peer review. Please submit your full paper online for evaluation.

Online Submission

We only accept manuscript submission via our online manuscript submission system. Before submitting a manuscript, authors are encouraged to consult both our Editorial Policies and the Submission Instructions for our online manuscript submission system. If you have not already done so, please register for an account with our online manuscript system. You will be able to monitor the status of your manuscript online throughout the editorial process.

Submission of Revisions

Authors submitting a revised manuscript after review are asked to include the following:

(1) A letter indicating point-by-point how you have addressed the comments raised by the editors and reviewers. If you disagree with any of the points raised, please provide adequate justification in your letter.

(2) A revised version of the manuscript that includes changes based on the comments raised by the editors and reviewers.

 

编辑

 

主编辑

Justin Stebbing,英国伦敦帝国学院

 

副编辑

Leandro Castellano,英国伦敦帝国学院

Georgios Giamas,英国苏塞克斯大学

Kristian Helin,丹麦哥本哈根大学

Michael Karin,加州大学圣地亚哥分校

Guillermina Lozano,美国德克萨斯

大学Donald McDonnell,杜克大学医学院,美国

Kevin Ryan,英国癌症研究所

副主编

Reuven Agami,荷兰荷兰癌症研究所

Simak Ali,英国伦敦帝国学院

Mark Bower,英国切尔西和威斯敏斯特医院

Jason Carroll,英国癌症研究英国

Graham Carpenter,美国Vanderbilt大学

Patrick Casey,新加坡杜克大学NUS医学院

Dipanjan Chowdhury,美国Dana-Farber癌症研究所

Ruggero De Maria,意大利圣心天主教

大学Dean Felsher,美国斯坦福大学

Gregory Goodall,澳大利亚癌症生物学中心

Andrei GudkovRoswell Park癌症研究所,美国

Christopher Heeschen,英国伦敦皇后大学

Patrick Hu,美国范德堡大学医学中心

Karen Knudsen,托马斯Jefferson大学

Jonathan Krell,英国伦敦帝国学院

Natasha Kyprianou,美国肯塔基大学

Jonathan Licht,美国佛罗里达大学

XinLu,英国牛津大学

Anders Lund,丹麦哥本哈根大学

Rene Medema,荷兰癌症研究所

George Miller,纽约大学癌症研究所,美国

Gordon Mills,美国德克萨斯大学

Kohei Miyazono,日本东京大学

Erik SahaiFrancis Crick英国

莱斯特大学Jacqui Shaw 英国莱斯特

大学中国科学院院士,中国

Grant Stewart英国

伯明翰大学James Woodgett,加拿大西奈山医院

Jindan Yu,美国西北大学,

Jun Jun,中国大学中华人民共和国

评论编辑

Guido KroemerCordeliers研究中心,法国

编辑委员会

Laura Attardi,美国斯坦福大学

Eric Baehrecke,美国马萨诸塞大学

Albert Baldwin,北卡罗来纳大学美国

Glen Barber,美国迈阿密大学

Jiri Bartek,丹麦癌症协会,丹麦

Amer BegMoffitt癌症中心,美国

Andrew Biankin ,英国格拉斯哥大学

Francois-Clement Bidard,法国居里研究所

Stephen Burley,美国新泽西州立大学

Arul Chinnaiyan,美国密歇根大学

Simon ChowdhuryGuy's医院,英国

Bruce ClurmanFred Hutchinson癌症研究中心,美国

Paul Davies,美国亚利桑那州立大学

J. Alan Diehl,美国南卡罗来纳医科大学

George Dranitsaris,约阿尼纳大学,希腊

Paul Frenette,阿尔伯特爱因斯坦医学院,美国

Irwin Gelman,美国Roswell公园癌症研究所

Michael Hayman,石溪大学,美国

Ricky Johnstone,澳大利亚Peter MacCallum癌症中心

Rakesh Kumar,乔治华盛顿大学,美国

Robert Langer,麻省理工学院,美国

Soo Chin Lee,国立大学癌症研究所,新加坡

Heinz Joseph Lenz,南加州大学,美国

David Lyden,美国康奈尔大学

Gerry Melino,罗马大学,意大利

Siddharta Mukherjee,美国哥伦比亚大学Salvatore

Papa,英国利兹大学

Jonathan Pollack,英国斯坦福大学

Carol Prives,哥伦比亚大学,美国

Martin Schuler,埃森大学医院,德国

Gregg Semenza,约翰霍普金斯大学,美国

Padmanee Sharma,美国德克萨斯大学

Maria SoengasCNIO,西班牙

Marius Sudol,新加坡分子和细胞生物学研究所

David Tuveson,冷泉港实验室,美国

Mark Vincent,伦敦加拿大地区癌症项目

Janindra Warusavitarne,英国St Marks医院

Keith Wilson,范德比尔特大学,美国

Jedd Wolchok,纪念斯隆凯特林癌症中心,美国

Gerard Zambetti,美国圣犹达儿童研究医院


投稿问答最小化  关闭